Benjamin R. Furman

Description of particle size, distribution, and behavior of talc preparations commercially available within the United States

Background: Widespread use of talc pleurodesis remains controversial for many providers concerned by adverse events such as respiratory failure, which are sometimes fatal. Particle talc size has been implicated in these adverse effects, mainly on the basis of animal studies utilizing large amounts of talc or in observational studies performed on different continents with different talc preparations and doses. Our aim was to determine the particle size and distribution of only the commercially available US-talc preparations and whether the fluid content can affect this distribution. Methods: Commercially available US talc was evaluated under scanning electron microscopy and dynamic light scattering (DLS). Distribution of talc particle size was obtained in saline and various protein-based solutions. Results: Talc particle size by DLS was performed with commercially available Sterile Talc Powder and Sclerosol Intrapleural Aerosol. Sterile Talc Powder demonstrated a median diameter of 26.57 &mgr;m with a range of particle sizes from 0.399 &mgr;m to 100.237 &mgr;m. Sclerosol demonstrated a median diameter of 24.49 &mgr;m with a range of particle sizes from 0.224 &mgr;m to 100.237 &mgr;m. The exposure of talc to a protein rich environment (bovine serum albumin and human pleural fluid) led to the development of measureable, new, larger aggregated particle (>100 &mgr;m). Conclusions: Currently available US talc seems to have size characteristics similar to previous described “graded” talc preparations. The exposure of talc to a protein rich environment seems to modify the overall distribution of talc particle size when examined by DLS.

Preparation of yttria-stabilized zirconia nanoplatelets using vacuum roll coating

Roll-to-roll vacuum coating on moving plastic substrates and the subsequent comminuting of the film into a flake or platelet with microscale lateral and thickness dimensions is an industrially mature technology utilized to produce clean, consistent material with high throughput. In this study, we describe the novel preparation of nanoplatelets by top-down vacuum evaporation of yttria-stabilized zirconium dioxides (YSZ) on a nanoembossed, moveable substrate for the purposes of making nanoplatelets. Microscopy and particle size analysis of the resulting YSZ nanoplatelets revealed that use of the nanoembossed substrate results in significant narrowing of the particle size distribution. However, while the YSZ coatings were conformal and successfully replicated the nanopattern of the underlying substrate, the stress in the film was inadequate to fracture the film into platelets that replicated the nanometer dimensions of the underlying pattern. It was determined that this is due to the inherent fracture toughness of the nanoplatelets and the augmented adhesion forces along the increased length scale of nanoparticle contacts. The nanoplatelets were further reduced in average size and size distribution by post-processing techniques of sonication, ball milling, and centrifugation. The nanoplatelet’s stoichiometry and crystallinity were modified by manipulating the source material, deposition parameters, and post-processing steps.